News

Public · Published

Rocket Lab stock slides despite record backlog, upbeat outlook

Rocket Lab shares fell around 7% in premarket trading Tuesday after the company reported a wider-than-expected third-quarter loss of $0.12 per share. Revenue rose 72.7% year over year to a record $267.8 million, backlog reached about $3.6 billion, and the company forecast fourth-quarter revenue of $270 million to $290 million.

Published:

Updated:

What happened

Rocket Lab shares fell around 7% in premarket trading Tuesday after the company reported a wider-than-expected third-quarter loss of $0.12 per share. Revenue rose 72.7% year over year to a record $267.8 million, backlog reached about $3.6 billion, and the company forecast fourth-quarter revenue of $270 million to $290 million.

Confirmed

Global impact / market context

The results show strong demand and sales growth, but the larger-than-expected loss indicates the company is not yet converting that growth into expected profit. More contracts and a higher launch price may support future revenue, while delayed Neutron service means those missions are not imminent.

Analyst inference

Investors faced conflicting signals: record revenue, backlog and an above-consensus fourth-quarter forecast contrasted with a wider loss. The article reports a roughly 7% premarket share decline, suggesting the earnings shortfall outweighed positive demand indicators in the immediate reaction.

Analyst inference

What to watch

  1. Watch whether Rocket Lab delivers its forecast of $270 million to $290 million in fourth-quarter revenue; results below that range could weaken confidence in its growth outlook. Confirmed
  2. Track progress toward Neutron’s first launch, targeted no earlier than 2027, and the delivery of first-flight hardware to Launch Complex 3; delays could defer related contract revenue. Confirmed
  3. Look for evidence that higher launch prices and new contracts improve profit per sale, which means revenue remaining after costs; the article does not yet show that improvement. Analyst inference

Evidence